Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Does levonorgestrel-releasing intrauterine system increase breast cancer risk in peri-menopausal women? An HMO perspective.

Siegelmann-Danieli N, Katzir I, Landes JV, Segal Y, Bachar R, Rabinovich HR, Bialik M, Azuri J, Porath A, Lomnicky Y.

Breast Cancer Res Treat. 2018 Jan;167(1):257-262. doi: 10.1007/s10549-017-4491-2. Epub 2017 Sep 14.

PMID:
28913650
2.

Primary prevention and screening practices among long-term breast cancer survivors.

Mandelzweig L, Chetrit A, Amitai T, Silverman B, Siegelmann-Danieli N, Sadetzki S.

Cancer Causes Control. 2017 Jul;28(7):657-666. doi: 10.1007/s10552-017-0891-1. Epub 2017 Apr 21.

PMID:
28432494
3.

Trends in annual drug expenditure - a 16 year perspective of a public healthcare maintenance organization.

Lomnicky Y, Kurnik D, Loebstein R, Katzir I, Vesterman-Landes J, Siegelmann-Danieli N.

Isr J Health Policy Res. 2016 Sep 15;5:37. doi: 10.1186/s13584-016-0096-1. eCollection 2016.

4.

A Novel Computational Tool for Mining Real-Life Data: Application in the Metastatic Colorectal Cancer Care Setting.

Siegelmann-Danieli N, Farkash A, Katzir I, Vesterman Landes J, Rotem Rabinovich H, Lomnicky Y, Carmeli B, Parush-Shear-Yashuv N.

PLoS One. 2016 May 4;11(5):e0154689. doi: 10.1371/journal.pone.0154689. eCollection 2016.

5.

Identification of health care needs of long-term breast cancer survivors among Israeli women.

Mandelzweig L, Chetrit A, Amitai T, Oberman B, Danieli NS, Silverman B, Sadetzki S.

Support Care Cancer. 2016 Feb;24(2):737-746. doi: 10.1007/s00520-015-2836-0. Epub 2015 Jul 21.

PMID:
26190362
6.

Resilience and psychosocial adjustment in digestive system cancer.

Gouzman J, Cohen M, Ben-Zur H, Shacham-Shmueli E, Aderka D, Siegelmann-Danieli N, Beny A.

J Clin Psychol Med Settings. 2015 Mar;22(1):1-13. doi: 10.1007/s10880-015-9416-9.

PMID:
25605269
7.

Where to die? That is the question: A study of cancer patients in Israel.

Barak F, Livshits S, Kaufer H, Netanel R, Siegelmann-Danieli N, Alkalay Y, Kreitler S.

Palliat Support Care. 2015 Apr;13(2):165-70. doi: 10.1017/S1478951513000904. Epub 2014 Feb 13.

PMID:
24524381
8.

The impact of the Oncotype DX Recurrence Score on treatment decisions and clinical outcomes in patients with early breast cancer: the Maccabi Healthcare Services experience with a unified testing policy.

Siegelmann-Danieli N, Silverman B, Zick A, Beit-Or A, Katzir I, Porath A.

Ecancermedicalscience. 2013 Dec 17;7:380. doi: 10.3332/ecancer.2013.380. eCollection 2013.

9.

A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer.

Yaal-Hahoshen N, Maimon Y, Siegelmann-Danieli N, Lev-Ari S, Ron IG, Sperber F, Samuels N, Shoham J, Merimsky O.

Oncologist. 2011;16(9):1197-202. doi: 10.1634/theoncologist.2011-0150. Epub 2011 Jun 28.

10.

The role of upper gastrointestinal swallow study in patients undergoing proximal or total gastrectomy.

Igor J, Poluksht N, Siegelmann-Danieli N, Lavy R, Wassermann I, Halpern Z, Gold-Deutch R, Halevy A.

Isr Med Assoc J. 2010 Sep;12(9):560-2.

11.

Factors affecting rise in the incidence of infiltrating lobular carcinoma of the breast.

Chikman B, Lavy R, Davidson T, Wassermann I, Sandbank J, Siegelmann-Danieli N, Halevy A.

Isr Med Assoc J. 2010 Nov;12(11):697-700.

12.

Trends in breast cancer incidence associated with reductions in the use of hormone replacement therapy.

Silverman BG, Siegelmann-Danieli N, Braunstein R, Kokia ES.

Cancer Epidemiol. 2011 Feb;35(1):11-6. doi: 10.1016/j.canep.2010.11.006. Epub 2010 Dec 15.

PMID:
21163720
13.

Potent CYP2D6 Inhibiting drugs do not increase relapse rate in early breast cancer patients treated with adjuvant tamoxifen.

Siegelmann-Danieli N, Kurnik D, Lomnicky Y, Vesterman-Landes J, Katzir I, Bialik M, Loebstein R.

Breast Cancer Res Treat. 2011 Jan;125(2):505-10. doi: 10.1007/s10549-010-1008-7. Epub 2010 Jul 1.

PMID:
20593233
14.

Dynamic computational model suggests that cellular citizenship is fundamental for selective tumor apoptosis.

Olsen M, Siegelmann-Danieli N, Siegelmann HT.

PLoS One. 2010 May 13;5(5):e10637. doi: 10.1371/journal.pone.0010637.

15.

Mitomycin C and vinblastine: an active regimen in previously treated breast cancer patients.

Ospovat I, Siegelmann-Danieli N, Grenader T, Hubert A, Hamburger T, Peretz T.

Tumori. 2009 Nov-Dec;95(6):683-6.

PMID:
20210229
16.

Israel-Gaza conflict.

Barak F, Siegelmann-Danieli N, Scharf S.

Lancet. 2009 Mar 14;373(9667):891. doi: 10.1016/S0140-6736(09)60536-5. No abstract available.

PMID:
19286077
17.

Orbital metastasis as the presenting symptom of extensive stage small cell lung cancer.

Henning M, Hu Q, Siegelmann-Danieli N.

Eur J Intern Med. 2008 Jan;19(1):65-6. doi: 10.1016/j.ejim.2007.03.011. Epub 2007 Sep 19.

PMID:
18206606
18.

[Molecular portrait of breast cancer with sub-classification of breast tumor].

Siegelmann-Danieli N, Stein ME, Wallach N.

Harefuah. 2007 Jan;146(1):48-52, 77-8. Review. Hebrew.

PMID:
17294849
19.

Breast cancer in elderly women: outcome as affected by age, tumor features, comorbidities, and treatment approach.

Siegelmann-Danieli N, Khandelwal V, Wood GC, Mainali R, Prichard J, Murphy TJ, Evans JF, Yumen O, Bernath AM.

Clin Breast Cancer. 2006 Apr;7(1):59-66.

PMID:
16764745
20.

Cystic-appearing pleural metastasis in a patient with recurrent phyllodes tumor.

Bucaloiu ID, Murphy T, Brown R, Siegelmann-Danieli N.

Breast J. 2005 Nov-Dec;11(6):482. No abstract available.

PMID:
16297102

Supplemental Content

Loading ...
Support Center